Long non-coding RNA LINC00525 interacts with miR-31-5p and miR-125a-5p to act as an oncogenic molecule in spinal...

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in cancer.
• The specific function and mechanism of LINC00525 in spinal chordoma remain largely unexplored.

Purpose of the Study:

• To investigate the role of LINC00525 in spinal chordoma.
• To elucidate the underlying molecular mechanism involving microRNAs.

Main Methods:

• Quantitative real-time polymerase chain reaction (qRT-PCR) for detecting LINC00525, miR-31-5p, and miR-125a-5p expression.
• In vitro studies involving LINC00525 downregulation in spinal chordoma cells to assess effects on proliferation, migration, invasion, apoptosis, and epithelial-mesenchymal transition (EMT).
• In vivo tumor xenograft models to evaluate LINC00525's effect on tumorigenesis.

Main Results:

• Spinal chordoma tissues exhibited high LINC00525 expression and low levels of miR-31-5p and miR-125a-5p.
• Downregulation of LINC00525 inhibited spinal chordoma cell proliferation, migration, invasion, and EMT, while promoting apoptosis.
• LINC00525 knockdown suppressed in vivo spinal chordoma tumorigenesis.
• MiR-31-5p and miR-125a-5p were identified as direct downstream targets of LINC00525.

Conclusions:

• LINC00525 promotes spinal chordoma tumorigenesis and progression by targeting miR-31-5p and miR-125a-5p.
• LINC00525 acts as an oncogenic lncRNA in spinal chordoma.
• LINC00525 represents a promising novel molecular target for spinal chordoma therapy.